These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 20623287)

  • 21. Lipid metabolism in Plasmodium falciparum-infected erythrocytes: possible new targets for malaria chemotherapy.
    Mitamura T; Palacpac NM
    Microbes Infect; 2003 May; 5(6):545-52. PubMed ID: 12758284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Common origin and fixation of Plasmodium falciparum dhfr and dhps mutations associated with sulfadoxine-pyrimethamine resistance in a low-transmission area in South America.
    McCollum AM; Mueller K; Villegas L; Udhayakumar V; Escalante AA
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2085-91. PubMed ID: 17283199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced heterozygosity at intragenic and flanking microsatellites of pfcrt gene establishes natural selection based molecular evolution of chloroquine-resistant Plasmodium falciparum in India.
    Mallick PK; Singh R; Singh OP; Singh AK; Bhasin VK; Valecha N
    Infect Genet Evol; 2013 Dec; 20():407-12. PubMed ID: 24126360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transmission dynamics of co-endemic Plasmodium vivax and P. falciparum in Ethiopia and prevalence of antimalarial resistant genotypes.
    Lo E; Hemming-Schroeder E; Yewhalaw D; Nguyen J; Kebede E; Zemene E; Getachew S; Tushune K; Zhong D; Zhou G; Petros B; Yan G
    PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005806. PubMed ID: 28746333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasmodium falciparum Resistance to a Lead Benzoxaborole Due to Blocked Compound Activation and Altered Ubiquitination or Sumoylation.
    Sindhe KMV; Wu W; Legac J; Zhang YK; Easom EE; Cooper RA; Plattner JJ; Freund YR; DeRisi JL; Rosenthal PJ
    mBio; 2020 Jan; 11(1):. PubMed ID: 31992618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential genetic hitchhiking around mutant pfcrt alleles in the Indian Plasmodium falciparum population.
    Lumb V; Madan R; Das MK; Rawat V; Dev V; Khan W; Khan H; Sharma YD
    J Antimicrob Chemother; 2012 Mar; 67(3):600-8. PubMed ID: 22207595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Malaria parasite genome scan: insights into antimalarial resistance.
    Gupta B; Awasthi G; Das A
    Parasitol Res; 2010 Jul; 107(2):495-9. PubMed ID: 20499094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evolution of Antimalarial Drug Resistance Markers in the Reservoir of Plasmodium falciparum Infections in the Upper East Region of Ghana.
    Narh CA; Ghansah A; Duffy MF; Ruybal-Pesántez S; Onwona CO; Oduro AR; Koram KA; Day KP; Tiedje KE
    J Infect Dis; 2020 Oct; 222(10):1692-1701. PubMed ID: 32459360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analyses of genetic variations at microsatellite loci present in-and-around the Pfcrt gene in Indian Plasmodium falciparum.
    Chauhan K; Pande V; Das A
    Infect Genet Evol; 2013 Dec; 20():476-87. PubMed ID: 24157593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The resistance of falciparum malaria in Africa to 4-aminoquinolines and antifolates.
    Schapira A
    Scand J Infect Dis Suppl; 1990; 75():1-64. PubMed ID: 2100881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The origins of antimalarial drug resistance.
    Hastings IM
    Trends Parasitol; 2004 Nov; 20(11):512-8. PubMed ID: 15471702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The genomic architecture of antimalarial drug resistance.
    Cowell AN; Winzeler EA
    Brief Funct Genomics; 2019 Sep; 18(5):314-328. PubMed ID: 31119263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tolerance is the key to understanding antimalarial drug resistance.
    Hastings IM; Watkins WM
    Trends Parasitol; 2006 Feb; 22(2):71-7. PubMed ID: 16406706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spread of anti-malarial drug resistance: mathematical model with implications for ACT drug policies.
    Pongtavornpinyo W; Yeung S; Hastings IM; Dondorp AM; Day NP; White NJ
    Malar J; 2008 Nov; 7():229. PubMed ID: 18976503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinically immune hosts as a refuge for drug-sensitive malaria parasites.
    Klein EY; Smith DL; Boni MF; Laxminarayan R
    Malar J; 2008 Apr; 7():67. PubMed ID: 18439283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complex dynamics and stability of resistance to antimalarial drugs.
    Hastings IM
    Parasitology; 2006 May; 132(Pt 5):615-24. PubMed ID: 16426485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Delaying antimalarial drug resistance with combination chemotherapy.
    White NJ
    Parassitologia; 1999 Sep; 41(1-3):301-8. PubMed ID: 10697872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In Vitro and Molecular Surveillance for Antimalarial Drug Resistance in Plasmodium falciparum Parasites in Western Kenya Reveals Sustained Artemisinin Sensitivity and Increased Chloroquine Sensitivity.
    Lucchi NW; Komino F; Okoth SA; Goldman I; Onyona P; Wiegand RE; Juma E; Shi YP; Barnwell JW; Udhayakumar V; Kariuki S
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7540-7. PubMed ID: 26392510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasmodium falciparum malaria: Convergent evolutionary trajectories towards delayed clearance following artemisinin treatment.
    Wilairat P; Kümpornsin K; Chookajorn T
    Med Hypotheses; 2016 May; 90():19-22. PubMed ID: 27063079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hitchhiking and selective sweeps of Plasmodium falciparum sulfadoxine and pyrimethamine resistance alleles in a population from central Africa.
    McCollum AM; Basco LK; Tahar R; Udhayakumar V; Escalante AA
    Antimicrob Agents Chemother; 2008 Nov; 52(11):4089-97. PubMed ID: 18765692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.